Ultrasonography‐Guided Core‐Needle Biopsy for Newly Diagnosed Large B-Cell Lymphomas: Analysis on Diagnostic Efficacy and Safety in an Italian Retrospective Study
Acta Haematologica · 26.05.2025 · 149 (3) · 241-251
DOI: 10.1159/000544794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, online erschienen am 26.05.2025. Verfasst von Marco Picardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples, Italy. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Image-Guided Biopsy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Excisional biopsy (EB) is the gold standard for large B-cell lymphomas (LBCLs) diagnosis. Based on recent advances in interventional radiology enabling accurate sampling with core needle biopsy (CNB), we evaluated efficacy and safety of CNB under imaging guidance for diagnosing LBCLs.
Methods
At the Hematology and Pathology Units of the Federico II University Medical School of Naples (Italy), we retrospectively collected patients with lymphadenopathies suspected of lymphomas (during 2009–2022) of which the ultrasonography (US)-guided CNB lymph node samples were available. Subsequently, we investigated the accuracy and safety of US-guided CNB for LBCLs diagnosis.
Results
Over a 12‐year period, 800 (superficial target, n = 560; deep‐seated target, n = 240) lymph node biopsies performed with 16‐gauge diameter modified Menghini needle under power‐Doppler ultrasonographic guidance have been evaluated in 800 patients. According to the reference standard, 220 were suffering from LBCLs (diffuse LBCL NOS [n = 196], and high-grade B-cell lymphoma with MYC and BCL2 rearrangements [n = 24]) subtypes, other malignancy subtypes (n = 510) and non-malignant findings (n = 70). For the series of LBCLs, the overall diagnostic accuracy of the micro‐histological sampling was 100% (95% confidence interval: 98%–100%). The complications occurred with very low incidence and severity (grade ≤2).
Conclusion
US-guided CNB is a less invasive method and can be considered an alternative to EB for LBCL diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples, Italy.
- Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples, Italy, claudiagiordano91.cg@gmail.com.
- Department of Advanced Biomedical Sciences, Federico II University Medical School, Naples, Italy.
- Department of Public Health, Federico II University Medical School Naples, Naples, Italy.
Zitieren
APA
Picardi, M., Giordano, C., Vincenzi, A., Pugliese, N., Scarpa, A., Mascolo, M., Vigliar, E., Troncone, G., Salvatore, C., & Pane, F. (2025). Ultrasonography‐Guided Core‐Needle Biopsy for Newly Diagnosed Large B-Cell Lymphomas: Analysis on Diagnostic Efficacy and Safety in an Italian Retrospective Study. Acta Haematologica, 149(3), 241-251. https://doi.org/10.1159/000544794
Vancouver
Picardi M, Giordano C, Vincenzi A, Pugliese N, Scarpa A, Mascolo M, et al. Ultrasonography‐Guided Core‐Needle Biopsy for Newly Diagnosed Large B-Cell Lymphomas: Analysis on Diagnostic Efficacy and Safety in an Italian Retrospective Study. Acta Haematologica. 2025;149(3):241-251. doi:10.1159/000544794
BibTeX
@article{Picardi2025,
author = {Picardi, Marco and Giordano, Claudia and Vincenzi, Annamaria and Pugliese, Novella and Scarpa, Alessia and Mascolo, Massimo and Vigliar, Elena and Troncone, Giancarlo and Salvatore, Claudia and Pane, Fabrizio},
title = {Ultrasonography‐Guided Core‐Needle Biopsy for Newly Diagnosed Large B-Cell Lymphomas: Analysis on Diagnostic Efficacy and Safety in an Italian Retrospective Study},
journal = {Acta Haematologica},
year = {2025},
volume = {149},
number = {3},
pages = {241--251},
doi = {10.1159/000544794}
}
EUVIMED